Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-024119

10% owner sold 307,779 shares at an average $46.96 ($14,452,394)

  • 10% owner acquired 2,671 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Avalon Ventures XI, L.P. · 10% owner

Table I: Non-derivative

22 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-26 Sale : show line 1 in the form −49,497 $46.78 $2,315,470 2,909,678 D
2024-09-26 Sale : show line 2 in the form −9,592 $46.78 $448,714 563,635 I
2024-09-26 Sale : show line 3 in the form −50,539 $46.78 $2,364,214 2,970,875 I
2024-09-26 Sale : show line 4 in the form −40,803 $47.77 $1,949,159 2,868,875 D
2024-09-26 Sale : show line 5 in the form −7,908 $47.77 $377,765 555,727 I
2024-09-26 Sale : show line 6 in the form −41,661 $47.77 $1,990,146 2,929,214 I
2024-09-27 Sale : show line 7 in the form −45,894 $46.42 $2,130,399 2,822,981 D
2024-09-27 Sale : show line 8 in the form −8,894 $46.42 $412,859 546,833 I
Open-market sales · 307,779 sh · avg $46.96 · $14,452,394

Table II: Derivative

8 lines
Date Transaction Shares Owned after D/I
2024-09-27 Exercise or conversion : show line 23 in the form Stock Option (right to buy) −828 28,178 D
2024-09-27 Exercise or conversion : show line 24 in the form Stock Option (right to buy) −345 11,741 D
2024-09-27 Exercise or conversion : show line 25 in the form Stock Option (right to buy) −345 11,741 D
2024-09-27 Exercise or conversion : show line 26 in the form Stock Option (right to buy) −234 7,839 D
2024-09-30 Exercise or conversion : show line 27 in the form Stock Option (right to buy) −434 27,744 D
2024-09-30 Exercise or conversion : show line 28 in the form Stock Option (right to buy) −181 11,560 D
2024-09-30 Exercise or conversion : show line 29 in the form Stock Option (right to buy) −181 11,560 D
2024-09-30 Exercise or conversion : show line 30 in the form Stock Option (right to buy) −123 7,716 D
Loading xslF345X05/form4-10012024_121033.xml…